FindTrial
Sign In

We want to compare the effect of 0.125 percent Bupivacaine versus 0.2 percent Ropivacaine wound instillation through surgical drain for post operative analgesia in patient undergoing modified radical mastectomy

A RANDOMIZED STUDY To Compare THE EFFECT OF 0.125 percent BUPIVACAINE VERSUS 0.2 percent Ropivacaine WOUND INSTILLATION THROUGH SURGICAL DRAIN FOR POSTOPERATIVE ANALGESIA IN PATIENTS UNDERGOING MODIFIED RADICAL MASTECTOMY -AT SMS MEDICAL COLLEGE JAIPUR. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088935
Enrollment
60
Registered
2025-06-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site Health Condition 2: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: 0.125% Bupivacaine wound instillation: The intervention involves the instillation of 0.125% Bupivacaine through the surgical drain placed in patients after undergoing a Modified Radical

Sponsors

SMS Medical College And Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing to give written and informed consent Patients undergoing Modified Radical Mastectomy either unilateral or bilateral Patients with ASA physical classification 1 or 2

Exclusion criteria

Exclusion criteria: Non Cooperative patients Patients allergic to the study drugs Pregnant and Lactating women

Design outcomes

Primary

MeasureTime frame
To assess and compare total number of rescue analgesic requirement in both groups Assess the post operative pain score using NRS scaleTimepoint: To assess and compare total number of rescue analgesic requirement in both groups at 2hour 4hour 6hour 12hour Assess the post operative pain score using NRS scale at 2hour 4hour 6hour 12hour—

Secondary

MeasureTime frame
To assess and compare the proportion of patients experiencing side effects To asses and compare the hemodynamic changes (HR SBP DBP)Timepoint: Upto 24 hours of extubation—

Countries

India

Contacts

Public ContactDR Lalit Mohan Jindal

SMS Medical College and Hospital

mdhaka86@gmail.com8696909181

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026